Comment on “The effectiveness of pembrolizumab maintenance with or without pemetrexed after induction treatment for advanced non-squamous Non–Small-Cell lung cancer”

IF 4.4 2区医学 Q1 ONCOLOGY

Lung Cancer Pub Date : 2025-08-24 DOI:10.1016/j.lungcan.2025.108725

M.M. Smeenk , V. van der Noort , C.J. de Gooijer , W.S.M.E. Theelen

引用次数: 0

查看原文本刊更多论文

关于“晚期非鳞状非小细胞肺癌诱导治疗后派姆单抗维持与培美曲塞或不培美曲塞的有效性”的评论

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lung Cancer 医学-呼吸系统

CiteScore

9.40

自引率

3.80%

发文量

407

审稿时长

25 days

期刊介绍： Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.